Weill Cornell Medicine
New York, 10021, United States
Location contact
Anais Rameau, MD
PRINCIPAL_INVESTIGATOR
Anaïs Rameau, MD
CONTACT
Christine Clark, MD
SUB_INVESTIGATOR
John Ramos, BA
CONTACT
(646) 962-7464 ext. 19882
NCT Number: NCT06579989
Investigators will assess the usefulness of using ultrasound in office procedures for laryngology interventions. Participants who qualify will be adults who are undergoing superior laryngeal nerve block, injection laryngoplasty, swallowing evaluation, voice evaluation and voice therapy.
Trial opening soon.
Get Notified18 year–99 year
All sexes
Interventional
Not applicable
New York, 10021, United States
Anais Rameau, MD
PRINCIPAL_INVESTIGATOR
Anaïs Rameau, MD
CONTACT
Christine Clark, MD
SUB_INVESTIGATOR
John Ramos, BA
CONTACT
(646) 962-7464 ext. 19882
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Adult patients who are seen at the Sean Parker Institute for the Voice and are determined to have neurogenic cough for which superior laryngeal nerve block is recommended will undergo this procedure under ultrasound guidance. Patients without neurogenic cough will also be recruited for ultrasound assessment to establish landmarks and normal variation. Patients will be assessed for their comfort with undergoing the procedure and clinicians will be surveyed on the ease and benefit of performing the procedure under ultrasound guidance.
Adult patients who are seen at the Sean Parker Institute for the Voice and are determined to have vocal fold atrophy or vocal fold paresis/paralysis for whom injection laryngoplasty is recommended will undergo laryngeal ultrasound prior to the procedure to assess baseline anatomy as well as following the procedure (both immediately following the procedure as well as at follow-up visits) in order to assess the amount of injectate.
Patients with and without swallowing complaints will be enrolled to assess their tongue, suprahyoid and infrahyoid musculature, including muscle identification, bulk and function.
Adult patients who are seen at the Sean Parker Institute for the Voice and are determined to have muscle tension dysphonia will undergo ultrasonography during their visit with laryngology or speech language pathology.
Time frame: Immediately post-intervention
The clinician will use the Likert scale and rate a series of statements on a scale of 1 (strongly disagree) to 5 (strongly agree). The lowest possible total score is 12 (overall clinician disagreement), and the highest possible total score is 60 (overall clinician agreement).
Time frame: Immediately post-intervention
The clinician will respond to the following open-ended questions:
Time frame: Day 1
Number of patients that fall into the below categories as determined by the provider care team:
Time frame: Day 1
The amount of time will be recorded in minutes.
Time frame: Day 1
This is a qualitative outcome measure. Providers will provide a description of the internal branch of superior laryngeal nerve anatomy with accompanying images from the strobe.
Time frame: Immediately post-intervention and at 4 week follow-up visit
The volume will be recorded in mL.
Time frame: Day 1
This is a qualitative outcome measure. Providers will provide a description of the tongue, suprahyoid, and infrahyoid musculature on ultrasound for patients with and without swallowing complaints.
Time frame: Day 1
This is a qualitative outcome measure. Providers will provide a description of the suprahyoid musculature on ultrasound for patients with muscle tension dysphonia.
Contact information is provided by the study sponsor or research team.
Joclin Rabinovich, BS
CONTACT
(646) 962-7464 ext. 19882
John Ramos, BA
CONTACT
(646) 962-7464 ext. 19882
Weill Medical College of Cornell University
Other
Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06999577
Cough, Deglutition Disorders
San Deigo, California, United States
View Trial DetailsNCT04362228
Alzheimer Disease, Basal Ganglia Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT00695227
Cough, Deglutition Disorders
Portland, Oregon, United States
View Trial DetailsNCT01637649
Brain Diseases, Cardiovascular Diseases
Bucheon-si, Gyenoggido, South Korea
View Trial Details